Anti-AMPK gamma 1 antibody [Y308]
- RabMAb
- Recombinant
- What is this?
5
(7 Reviews)
|
(27 Publications)
Rabbit Recombinant Monoclonal AMPK gamma 1 antibody. Suitable for IP, WB, Flow Cyt (Intra) and reacts with Human, Mouse, Rat samples. Cited in 27 publications.
View Alternative Names
5'-AMP-activated protein kinase subunit gamma-1, AMPK gamma1, AMPK subunit gamma-1, AMPKg, PRKAG1
- Flow Cyt (Intra)
Lab
Flow Cytometry (Intracellular) - Anti-AMPK gamma 1 antibody [Y308] (AB32508)
Intracellular Flow Cytometry analysis of HeLa (Human cervix adenocarcinoma epithelial cell) cells labeling AMPK gamma 1 with ab32508 at 1/100 dilution (1μg) (Red). Goat anti rabbit IgG (Alexa Fluor®488, ab150077) at 1/2000 dilution was used as the secondary antibody. Cells were fixed with4% paraformaldehyde. Rabbit monoclonal IgG (ab172730) was used as isotype control (Black). Unlabelled control : Cells without incubation with primary antibody and secondary antibody (Blue).
- IP
Lab
Immunoprecipitation - Anti-AMPK gamma 1 antibody [Y308] (AB32508)
AMPK gamma 1 was immunoprecipitated using 1 mg Jurkat whole cell extract, 0.2 ug of Rabbit monoclonal [Y308] to AMPK gamma 1and 50μl of protein G magnetic beads (lane 1). The antibody was incubated with the Protein G beads for 10min under agitation. No antibody was added to the control (lane 2). Jurkat whole cell extractdiluted in RIPA buffer was added to each sample and incubated for 10min under agitation. Proteins were eluted by addition of 40μl SDS loading buffer and incubated for 10min at 70oC; 10μl of each sample was separated on a SDS PAGE gel, transferred to a nitrocellulose membrane, blocked with 5% BSA and probed with ab32508. Secondary : Mouse monoclonal [SB62a] Secondary Antibody to Rabbit IgG light chain (HRP) (ab99697). Bands : 37kDa : AMPK gamma 1.
All lanes:
Immunoprecipitation - Anti-AMPK gamma 1 antibody [Y308] (ab32508)
Predicted band size: 38 kDa
false
- WB
AbReview39625****
Western blot - Anti-AMPK gamma 1 antibody [Y308] (AB32508)
All lanes:
Western blot - Anti-AMPK gamma 1 antibody [Y308] (ab32508) at 1/1000 dilution
All lanes:
HEK293 whole cell lysate at 30 µg
Secondary
All lanes:
Alexa Fluor® 690-conjugated Goat anti-rabbit IgG polyclonal at 1/10000 dilution
Predicted band size: 38 kDa
Observed band size: 38 kDa
false
Exposure time: 5min
This image is courtesy of an anonymous Abreview
- WB
Unknown
Western blot - Anti-AMPK gamma 1 antibody [Y308] (AB32508)
All lanes:
Western blot - Anti-AMPK gamma 1 antibody [Y308] (ab32508) at 1/1000 dilution
All lanes:
Jurkat cell lysate
Predicted band size: 38 kDa
Observed band size: 38 kDa
false
- WB
CiteAb
Western blot - Anti-AMPK gamma 1 antibody [Y308] (AB32508)
Western Blotting using Anti-AMPK gamma 1 antibody [Y308], ab32508. Publication image from Yan, Z. et al., 2017, Nat Commun, 28916822. Legend direct from paper.
Ampk, Ulk1 and Drp1, are transiently activated immediately following acute exercise. Ampk and its substrate Acc are phosphorylated at Thr172 a, b and S79 a, c, respectively, immediately after the cessation of exercise and return to baseline values by 3 h post-exercise in C57BL/6 J mice aged 10–12 weeks. Ulk1 is phosphorylated at Ser555, but not Ser467 or Ser757, immediately following acute exercise, which returns to basal levels by 3 h post-exercise a, d–f. Drp1 is phosphorylated in skeletal muscle at Ser616 a, g immediately after the cessation of exercise and Ser637 a, h reaching significance 3 and 6 h after exercise. Mfn2 protein abundance is unchanged following acute treadmill running a, i. Representative western blots are shown a and all quantification is presented as protein phosphorylation to total protein abundance ratio b–f. Data presented as mean ± standard error of the mean. n = 5 (except 24 h, n = 4). See also Supplementary Figs. 6 and 7. Results of one-way ANOVAs are *p < 0.05, **p < 0.01. F = 6.44 for b, F = 3.56 for c, F = 6.50 for d, F = 0.89 for e, F = 0.33 for f, F = 3.34 for g, F = 2.76 for h, F = 0.31 i. DF = 5. p-Ampk (T172/Total) b was sqrt transformed to account for unequal variance., DF = 5. S637/total Drp1 data was log transformed to account for unequal variance
false
- WB
CiteAb
Western blot - Anti-AMPK gamma 1 antibody [Y308] (AB32508)
Western Blotting using Anti-AMPK gamma 1 antibody [Y308], ab32508. Publication image from Yan, Z. et al., 2017, Nat Commun, 28916822. Legend direct from paper.
Ampk is necessary and sufficient for phosphorylation of Ulk1 at Ser555 in response to acute exercise. Phosphorylation of Ampk at T172 in response to acute exercise is blocked in Ampk dnTG a, b, whereas increased phosphorylation of Acc at Ser79 post-exercise is still observed a, c. In Ampk caTG mice, both T172 Ampk and S79 Acc are elevated in sedentary conditions f–h. Phosphorylation of Ulk1 at Ser555 is blunted in dnTG skeletal muscle immediately after acute exercise a, d but elevated in caTG mice basally f, i. There was no effect on S757 phosphorylation in either dnTG mice post exercise a, e or sedentary caTG mice (f, j). Representative western blots are shown for dnTG mice a and caTG mice f. See also Supplementary Figs. 8 and 9. All quantification is presented as protein phosphorylation to total protein abundance ratio b–e, g–j. Data are presented as mean ± standard error of the mean. For dnTG study n = 10 WT or 5–7 dnTG (12–13 weeks). Results of two-way ANOVAs are *p < 0.05, **p < 0.01 for sedentary vs. exercise comparisons, F = 4.57 and DF = 1 c. ###p < 0.001 for between group comparisons, F = 14.03 and DF = 1 (e). Tukey multiple comparison tests were performed when a significant interaction effect was observed, in which *p < 0.05, **p < 0.01 for WT sedentary vs. WT exercise comparisons and $$p < 0.01, $$$p < 0.001 for WT exercise vs. dnTG exercise comparisons, DF = 27. For caTG study n = 3 (WT) or 5 (caTG) (13–15 weeks). Results of two-tailed t-tests are *p < 0.05 and **p < 0.01 for WT to caTG comparisons, t = 4.94 (g), t = 2.57 (h), t = 2.71 (i), t = 1.72 (j), DF = 6
false
- WB
CiteAb
Western blot - Anti-AMPK gamma 1 antibody [Y308] (AB32508)
Western Blotting using Anti-AMPK gamma 1 antibody [Y308], ab32508. Publication image from Yan, Z. et al., 2017, Nat Commun, 28916822. Legend direct from paper.
Ampk is necessary and sufficient for phosphorylation of Ulk1 at Ser555 in response to acute exercise. Phosphorylation of Ampk at T172 in response to acute exercise is blocked in Ampk dnTG a, b, whereas increased phosphorylation of Acc at Ser79 post-exercise is still observed a, c. In Ampk caTG mice, both T172 Ampk and S79 Acc are elevated in sedentary conditions f–h. Phosphorylation of Ulk1 at Ser555 is blunted in dnTG skeletal muscle immediately after acute exercise a, d but elevated in caTG mice basally f, i. There was no effect on S757 phosphorylation in either dnTG mice post exercise a, e or sedentary caTG mice (f, j). Representative western blots are shown for dnTG mice a and caTG mice f. See also Supplementary Figs. 8 and 9. All quantification is presented as protein phosphorylation to total protein abundance ratio b–e, g–j. Data are presented as mean ± standard error of the mean. For dnTG study n = 10 WT or 5–7 dnTG (12–13 weeks). Results of two-way ANOVAs are *p < 0.05, **p < 0.01 for sedentary vs. exercise comparisons, F = 4.57 and DF = 1 c. ###p < 0.001 for between group comparisons, F = 14.03 and DF = 1 (e). Tukey multiple comparison tests were performed when a significant interaction effect was observed, in which *p < 0.05, **p < 0.01 for WT sedentary vs. WT exercise comparisons and $$p < 0.01, $$$p < 0.001 for WT exercise vs. dnTG exercise comparisons, DF = 27. For caTG study n = 3 (WT) or 5 (caTG) (13–15 weeks). Results of two-tailed t-tests are *p < 0.05 and **p < 0.01 for WT to caTG comparisons, t = 4.94 (g), t = 2.57 (h), t = 2.71 (i), t = 1.72 (j), DF = 6
false
Related conjugates and formulations (1)
-
Anti-AMPK gamma 1 antibody [Y308] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (27)
Recent publications for all applications. Explore the full list and refine your search
Nature 633:189-197 PubMed39143206
2024
Applications
Unspecified application
Species
Unspecified reactive species
iScience 27:108852 PubMed38303706
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cell chemical biology 30:1585-1600.e6 PubMed37890479
2023
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of biological chemistry 298:101852 PubMed35331736
2022
Applications
Unspecified application
Species
Unspecified reactive species
Aging 13:16834-16858 PubMed34166224
2021
Applications
Unspecified application
Species
Unspecified reactive species
Pharmaceuticals (Basel, Switzerland) 14: PubMed34073624
2021
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in pharmacology 12:630210 PubMed33841151
2021
Applications
Unspecified application
Species
Unspecified reactive species
Molecular metabolism :101183 PubMed33548500
2021
Applications
Unspecified application
Species
Unspecified reactive species
Molecular therapy : the journal of the American So 28:1133-1153 PubMed32087766
2020
Applications
Unspecified application
Species
Unspecified reactive species
Cell death & disease 11:115 PubMed32051395
2020
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com